Evidence map›Paper›PMID 35912819›Full record

ArticleDrug delivery2022

Improving cellular uptake and bioavailability of periplocymarin-linoleic acid prodrug by combining PEGylated liposome.

Huiyun Zhang, Shunru Wei, Yu Zhang, Anran Pan, Michael Adu-Frimpong, Congyong Sun, Gang Qi

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Drug delivery, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.7field-weighted citation impact, top 33% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 8 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

Huiyun ZhangSchool of Chemistry and Chemical Engineering, Yancheng Institute of Technology, Yancheng, Jiangsu, China.
Shunru WeiSchool of Chemistry and Chemical Engineering, Yancheng Institute of Technology, Yancheng, Jiangsu, China.
Yu ZhangSchool of Chemistry and Chemical Engineering, Yancheng Institute of Technology, Yancheng, Jiangsu, China.
Anran PanSchool of Chemistry and Chemical Engineering, Yancheng Institute of Technology, Yancheng, Jiangsu, China.
Michael Adu-FrimpongDepartment of Biochemistry and Forensic Sciences, School of Chemical and Biochemical Sciences, C. K. Tedam University of Technology and Applied Sciences (CKT-UTAS), Navrongo, Ghana.
Congyong SunDepartment of Central Laboratory, The Affiliated Huai'an No. 1 People's Hospital, Nanjing Medical University, Huai'an, China.
Gang QiSchool of Chemistry and Chemical Engineering, Yancheng Institute of Technology, Yancheng, Jiangsu, China.
Yancheng Institute of Technology · CNC.K. Tedam University of Technology and Applied SciencesXuzhou Medical College · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Periplocymarin (PPM), a cardiac glycoside isolated from

Indexed as

Cardiac GlycosidesProdrugsBiological AvailabilityLinoleic AcidLiposomesPolyethylene GlycolsCardiac GlycosidesLinoleic AcidLiposomesperiplocymarinPolyethylene GlycolsProdrugsPEGylated liposomePeriplocymarinsmall molecule prodrug

Identifiers

PMID35912819
PMCPMC9344961
OpenAlexW4289174579

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.